Question 1

What are the main differences between the GSK vaccine and Gardasil®?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age clinical trial (NCT00423046). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my participation in this trial help improve HPV vaccination options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age clinical trial (NCT00423046). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of each vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age clinical trial (NCT00423046). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age clinical trial (NCT00423046). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience any side effects after vaccination?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age clinical trial (NCT00423046). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I receive any compensation for participating in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age clinical trial (NCT00423046). Contact the study team or your healthcare provider for specific answers.

What this study is about